David R. Ebsworth

David R. Ebsworth (board member) discloses dealings in Verona Pharma plc to SEC (Form 4). Between 4 May 2021 and 7 October 2025, the trades on record add up to 9 filings.

On the open market, the record shows 4 purchases worth €646k and 1 sale worth €7,816. The net balance comes to €638k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 option exercises.

The median purchase comes to €134k. On 2 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 8 October 2025, the filings show a transaction in Verona Pharma plc. The latest purchase dates back some time: it was published 699 days ago, on 18 November 2024. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.